(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LEUKEMIA & LYMPHOMA SOCIETY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LEUKEMIA & LYMPHOMA SOCIETY

ST13

US500000086902402

Class

16, 35, 36

Filing

86902402

Registration

5098957

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

12/14/2025

Trademark type

Word

Nice classes

16, 35, 36

Filing date

02/09/2016

Registration date

12/13/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/25/2023

Last transaction

12/14/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

1999-00-00

First use in commerce

1999-00-00

Drawing code

4

Owner type

99

Owner location

WASHINGTON, DC

Examiner

CHANG,KATHERINE S

Law office

M60

Current location

TMO LAW OFFICE 115

Holders and representatives

Holders

BLOOD CANCER UNITED , INC.
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc.

Representatives

Andrew D. Price Venable LLP

Technical classification

Nice Classes

Class 16Class 35Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 16

Pamphletsbrochuresbooks and newsletters relating to blood related cancers and blood related cancer research

Class 35

Association servicespromoting the public interest and awareness in cancer research and education

Class 36

Charitable fund raising services relating to blood related cancers

Publications

History of USPTO decisions and trademark events.

31 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/13/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/01/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/25/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/25/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/25/2023

E815

TEAS SECTION 8 & 15 RECEIVED

05/26/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/13/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/10/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/10/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

12/13/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/27/2016

PUBO

PUBLISHED FOR OPPOSITION

09/27/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/07/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/06/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/06/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/12/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

08/12/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/12/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

08/12/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/12/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/11/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/10/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/10/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/10/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/25/2016

GNRT

NON-FINAL ACTION E-MAILED

05/25/2016

CNRT

NON-FINAL ACTION WRITTEN

05/25/2016

DOCK

ASSIGNED TO EXAMINER

05/25/2016

MPMK

NOTICE OF PSEUDO MARK E-MAILED

02/13/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/12/2016

NWAP

NEW APPLICATION ENTERED

02/12/2016

Continuous trademark protection

Get notified about every new filing that threatens LEUKEMIA & LYMPHOMA SOCIETY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.